	1 2
Frontiers in Pharmacology	Frontiers in Pharmacology, 2, 13.33% Frontiers in Pharmacology 2 publications, 13.33%
Frontiers in Physiology	Frontiers in Physiology, 1, 6.67% Frontiers in Physiology 1 publication, 6.67%
Naunyn-Schmiedeberg's Archives of Pharmacology	Naunyn-Schmiedeberg's Archives of Pharmacology, 1, 6.67% Naunyn-Schmiedeberg's Archives of Pharmacology 1 publication, 6.67%
Obesities	Obesities, 1, 6.67% Obesities 1 publication, 6.67%
Gene	Gene, 1, 6.67% Gene 1 publication, 6.67%
Russian Chemical Reviews	Russian Chemical Reviews, 1, 6.67% Russian Chemical Reviews 1 publication, 6.67%
Agriculture (Switzerland)	Agriculture (Switzerland), 1, 6.67% Agriculture (Switzerland) 1 publication, 6.67%
International Journal of Pharmaceutics	International Journal of Pharmaceutics, 1, 6.67% International Journal of Pharmaceutics 1 publication, 6.67%
Molecular Pharmaceutics	Molecular Pharmaceutics, 1, 6.67% Molecular Pharmaceutics 1 publication, 6.67%
Phytomedicine	Phytomedicine, 1, 6.67% Phytomedicine 1 publication, 6.67%
Nutrients	Nutrients, 1, 6.67% Nutrients 1 publication, 6.67%
Digestion	Digestion, 1, 6.67% Digestion 1 publication, 6.67%
Journal of Drug Delivery Science and Technology	Journal of Drug Delivery Science and Technology, 1, 6.67% Journal of Drug Delivery Science and Technology 1 publication, 6.67%
Gels	Gels, 1, 6.67% Gels 1 publication, 6.67%
	1 2

Publishers

	1 2 3 4
MDPI	MDPI, 4, 26.67% MDPI 4 publications, 26.67%
Elsevier	Elsevier, 4, 26.67% Elsevier 4 publications, 26.67%
Frontiers Media S.A.	Frontiers Media S.A., 3, 20% Frontiers Media S.A. 3 publications, 20%
Springer Nature	Springer Nature, 1, 6.67% Springer Nature 1 publication, 6.67%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii	Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii, 1, 6.67% Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii 1 publication, 6.67%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 6.67% American Chemical Society (ACS) 1 publication, 6.67%
S. Karger AG	S. Karger AG, 1, 6.67% S. Karger AG 1 publication, 6.67%
	1 2 3 4

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Cai J. et al. Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling. // Tohoku Journal of Experimental Medicine. Vol. 261. No. 4.

GOST all authors (up to 50) Copy

Cai J., Zhu Y., Li X., Deng G., Han Y., Yuan F., Yi G., Xia X. Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling. // Tohoku Journal of Experimental Medicine. Vol. 261. No. 4.

RIS

Cite this

RIS Copy

TY - JOUR

DO - 10.1620/tjem.2023.J050

UR - https://doi.org/10.1620/tjem.2023.J050

TI - Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling.

T2 - Tohoku Journal of Experimental Medicine

AU - Cai, Jialuo

AU - Zhu, Yilin

AU - Li, Xiaoping

AU - Deng, Guiming

AU - Han, Yuanshan

AU - Yuan, Feiyun

AU - Yi, Gangqiang

AU - Xia, Xinhua

DA - 2023/12/16

PB - Tohoku University Medical Press

IS - 4

VL - 261

PMID - 37344419

SN - 0040-8727

SN - 1349-3329

ER -

Publisher

Tohoku University Medical Press

Journal

Tohoku Journal of Experimental Medicine

scimago Q2

wos Q2

SJR

0.460

CiteScore

2.8

Impact factor

1.6

ISSN

00408727 (Print)

13493329 (Electronic)